rs78223661
Variant names:
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_014141.6(CNTNAP2):c.551-11T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000543 in 1,609,390 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0020 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00039 ( 0 hom. )
Consequence
CNTNAP2
NM_014141.6 intron
NM_014141.6 intron
Scores
2
Splicing: ADA: 0.0001910
2
Clinical Significance
Conservation
PhyloP100: 0.0860
Publications
2 publications found
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
- complex neurodevelopmental disorderInheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
- cortical dysplasia-focal epilepsy syndromeInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 7-147108136-T-G is Benign according to our data. Variant chr7-147108136-T-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 95575.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS2
High Homozygotes in GnomAd4 at 2 AR,AD gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CNTNAP2 | NM_014141.6 | c.551-11T>G | intron_variant | Intron 4 of 23 | ENST00000361727.8 | NP_054860.1 | ||
CNTNAP2 | XM_017011950.3 | c.551-11T>G | intron_variant | Intron 4 of 13 | XP_016867439.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00199 AC: 302AN: 151828Hom.: 2 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
302
AN:
151828
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000626 AC: 156AN: 249056 AF XY: 0.000541 show subpopulations
GnomAD2 exomes
AF:
AC:
156
AN:
249056
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000392 AC: 571AN: 1457444Hom.: 0 Cov.: 32 AF XY: 0.000363 AC XY: 263AN XY: 725248 show subpopulations
GnomAD4 exome
AF:
AC:
571
AN:
1457444
Hom.:
Cov.:
32
AF XY:
AC XY:
263
AN XY:
725248
show subpopulations
African (AFR)
AF:
AC:
228
AN:
33360
American (AMR)
AF:
AC:
29
AN:
44530
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
26084
East Asian (EAS)
AF:
AC:
8
AN:
39626
South Asian (SAS)
AF:
AC:
7
AN:
86014
European-Finnish (FIN)
AF:
AC:
2
AN:
52756
Middle Eastern (MID)
AF:
AC:
6
AN:
5704
European-Non Finnish (NFE)
AF:
AC:
243
AN:
1109148
Other (OTH)
AF:
AC:
47
AN:
60222
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
25
51
76
102
127
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00199 AC: 303AN: 151946Hom.: 2 Cov.: 32 AF XY: 0.00211 AC XY: 157AN XY: 74266 show subpopulations
GnomAD4 genome
AF:
AC:
303
AN:
151946
Hom.:
Cov.:
32
AF XY:
AC XY:
157
AN XY:
74266
show subpopulations
African (AFR)
AF:
AC:
269
AN:
41454
American (AMR)
AF:
AC:
15
AN:
15248
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3464
East Asian (EAS)
AF:
AC:
2
AN:
5162
South Asian (SAS)
AF:
AC:
1
AN:
4818
European-Finnish (FIN)
AF:
AC:
0
AN:
10550
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
11
AN:
67934
Other (OTH)
AF:
AC:
5
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
18
37
55
74
92
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not specified Uncertain:1Benign:2
Sep 13, 2024
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Aug 20, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jun 12, 2013
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Cortical dysplasia-focal epilepsy syndrome Benign:1
Jan 15, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.